Filing Details

Accession Number:
0001127602-17-009254
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-03-01 16:18:57
Reporting Period:
2017-02-27
Filing Date:
2017-03-01
Accepted Time:
2017-03-01 16:18:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875045 Biogen Inc. BIIB Biological Products, (No Disgnostic Substances) (2836) 330112644
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1672709 Michel Vounatsos Biogen Inc.
225 Binney St.
Cambridge MA 02142
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-02-27 1,333 $285.39 1,434 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Purchase pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
  2. Includes 100.9310 shares acquired under the Biogen Inc. employee stock purchase plan on 09/30/16 and 12/30/16.